A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia (Q34974099)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia |
scientific article |
Statements
1 reference
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia (English)
1 reference
O Freudenreich
1 reference
C P Borba
1 reference
D C Henderson
1 reference
X Fan
1 reference
B Sharma
1 reference
P M Copeland
1 reference
R Boxill
1 reference
C Cather
1 reference
A Eden Evins
1 reference
D C Goff
1 reference
12 January 2009
1 reference
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference